Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.47 |
| ▸ | FDPS | P14324 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1478231 | 1.00 | ALOX15 (0.53) | ALOX15ALDH1A1GGPS1FDPSTSHR | |
| SCHEMBL1477739 | 1.00 | ALOX15 (0.53) | ALOX15ALDH1A1GGPS1FDPSTSHR | |
| SCHEMBL10730947 | 0.90 | FNTA (0.50) | ALOX15ALDH1A1POLB | |
| SCHEMBL10730955 | 0.90 | FNTA (0.50) | ALOX15ALDH1A1POLB | |
| SCHEMBL10750006 | 0.90 | FNTA (0.50) | ALOX15ALDH1A1POLB | |
| SCHEMBL6050718 | 0.83 | ALOX15 (0.57) | ALOX15ALDH1A1GGPS1FDPSTSHR | |
| SCHEMBL5136231 | 0.83 | ALOX15 (0.57) | ALOX15ALDH1A1GGPS1FDPSTSHR | |
| SCHEMBL4608511 | 0.83 | ALOX15 (0.57) | ALOX15ALDH1A1GGPS1FDPSTSHR | |
| SCHEMBL991834 | 0.83 | ALOX15 (0.57) | ALOX15ALDH1A1GGPS1FDPSTSHR | |
| Citronellic Acid SCHEMBL193354 | 0.82 | ALOX15 (0.55) | ALOX15ALDH1A1GGPS1FDPSTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2064169-B1 | RECOVERY OF BIS(DIARYLPHENOL) LIGANDS DURING THE PRODUCTION OF ISOPULEGOL | BASF SE (DE) | 2016-03-23 | — | — | EP | disclosed |
| EP-2755949-B1 | FUNGICIDAL 4-SUBSTITUTED-3-{PHENYL[(HETEROCYCLYLMETHOXY)IMINO]METHYL}-1,2,4-OXADIZOL-5(4H)-ONE DERIVATIVES | BAYER IP GMBH (DE) | 2015-10-21 | — | — | EP | disclosed |
| US-9090600-B2 | Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadizol-5(4H)-one derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-07-28 | — | — | US | disclosed |
| US-20140349848-A1 | FUNGICIDAL 4-SUBSTITUTED-3--1,2,4-OXADIZOL-5(4H)-ONE DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-11-27 | — | — | US | disclosed |
| EP-2612923-A1 | METHOD FOR SEARCHING FOR MALODOR CONTROL AGENT, MALODOR CONTROL AGENT, AND MALODOR CONTROL METHOD | Kao Corporation (JP) | 2013-07-10 | — | — | EP | disclosed |
| EP-1802561-B1 | METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE CARBONYL COMPOUNDS | BASF SE (DE) | 2011-01-12 | — | — | EP | disclosed |
| EP-1858903-B1 | DIARYLPHENOXY ALUMINUM COMPOUNDS | BASF SE (DE) | 2008-10-08 | — | — | EP | disclosed |
| WO-2008088314-A2 | A COMPOSITION FOR THE TREATMENT AND PREVENTION OF PEPTIC ULCER | MEDIGREEN BIOTECHNOLOGY CORP. (TW) | 2008-07-24 | — | — | WO | disclosed |
| US-20080145409-A1 | COMPOSITION FOR THE TREATMENT AND PREVENTION OF PEPTIC ULCER | MEDIGREEN BIOTECHNOLOGY CORP. (TW) | 2008-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140349848-A1 | FUNGICIDAL 4-SUBSTITUTED-3--1,2,4-OXADIZOL-5(4H)-ONE DERIVATIVES | CYP4X1, CYP4B1, CYP4Z1 | ALOX15 2823/4885ALDH1A1 232/4885GGPS1 3711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.